Michael Rosenblatt
Co-Chair, Galien Forum
Senior Partner, Flagship Pioneering
Cambridge, MA
PANEL 1: 8AM – 9AM
The future is decentralized — How the paradigm has changed and what it means for modern trials?
Chair:
MaryAnne Rizk
Chief Strategy Officer, Medable
Panelists:
Robert Califf
Head of Clinical Policy & Strategy, Verify and Google Health; Adjunct Professor, Duke University & Stanford University;
Former FDA Deputy Commissioner to President Barack Obama
Cristina Durán
Chief Digital Health Officer, R&D, AstraZeneca
Sebastian Guth
President of Bayer Pharmaceuticals, Americas Region
Michelle Longmire
Co-founder & CEO, Medable
Andy Plump
President, Research & Development, Takeda Pharmaceuticals Company Ltd
PANEL 2: 9AM – 10AM
Future pathways in translational medicine — Academic industry collaborations in CNS diseases
Chair:
Ann Graybiel
Institute Professor, Department of Brain and Cognitive Science, MIT
Panelists:
Dan Grossman
Managing Director and Senior Partner, Boston Consulting Group
Kelsey Martin
Director, Simons Foundation Autism Research Initiative (SFARI)
Michel Pairet
Member of the Board of Managing Directors – Innovation, Boehringer Ingelheim
Jay Stamatis
Vice President, Head of Business Development and Acquisitions, AbbVie
Co-Chairs:
Joel S. Marcus
Co-Founder, Alexandria Summit;
Executive Chairman & Founder, Alexandria Real Estate Equities, Inc./Alexandria Venture Investments
Lynne Zydowsky
President & Co-Founder, Alexandria Summit;
Chief of Science, Alexandria Real Estate Equities, Inc./Alexandria Venture Investments
Panelists:
The Honorable Patrick J. Kennedy
Former U.S. Representative (D-RI); Founder, The Kennedy Forum; Former Member, President’s Commission on Combating Drug Addiction and the Opioid Crisis; Co-Founder, One Mind; Co-Founder, Mental Health for US
Richard Pops
Chairman & Chief Executive Officer, Alkermes
Marti Taylor
President & Chief Executive Officer, OneFifteen
KEYNOTE: 11:30AM – 12PM
The importance of research and lessons learned from the pandemic
Ken Frazier
Executive Chairman of the Board of Directors, Merck & Co., Inc.
PANEL 4: 12PM – 1:15PM
Vaccines, drugs & the future of pandemics — Lessons from Covid-19
Co-Chairs:
Sue Desmond-Hellmann
Prix Galien Committee Chair, Galien Forum Co-Chair & Former CEO, Bill & Melinda Gates Foundation
Julie Sweet
CEO & Chair of the Board, Accenture
Panelists:
Stéphane Bancel
CEO, Moderna
Albert Bourla
Chairman & CEO, Pfizer
Alex Gorsky
Chairman, Board of Directors & CEO, Johnson & Johnson
Leonard Schleifer
Founder, President & CEO, Regeneron
Daniel M. Skovronsky
President Lilly Research Laboratories, Chief Scientific & Medical Officer, Eli Lilly and Company
Pascal Soriot
Chairman & CEO, AstraZeneca
Anthony S. Fauci
Director, National Institute of Allergy and Infectious Diseases & Chief Advisor to the President of the United States
PANEL 5: 3PM – 4:15PM
New breakthroughs in the biology of cancer: Pioneering novel ways to enhance and restore the body’s ability to fight cancer
Chair:
Laurie Glimcher
President & CEO, Dana-Farber Cancer Institute
Panelists:
Scott Armstrong
President, Boston Children’s Cancer & Blood Disorders Center; Chairman, Department of Pediatric Oncology, Dana-Farber Cancer Institute
Danny Bar-Zohar
Global Head of Development, Merck KGaA
Samit Hirawat
Executive Vice President, Chief Medical Officer, Global Drug Development, Bristol Myers Squibb
William Kaelin
Sidney Farber Professor of Medicine, Harvard Medical School and Dana-Farber Cancer Institute
Crystal Mackall
Ernest & Amelia Gallo Family Professor of Pediatrics & Internal Medicine, Stanford University
PANEL 6: 4:15PM – 5:30PM
Where will new therapies and vaccines come from?
Chair:
Mikael Dolsten
Chief Scientific Officer & President, Worldwide Research, Development and Medical, Pfizer
Panelists:
Robert Bradway
Chairman & CEO, Amgen
Michelle McMurry-Heath
President & CEO, BIO
Jeffrey A. Spaeder
Chief Medical and Scientific Officer, and Senior Vice President, IQVIA
Michel Vounatsos
Chairman & CEO, Biogen
Sue Desmond-Hellmann
Prix Galien Committee Chair, Galien Forum Co-Chair & Former CEO, Bill & Melinda Gates Foundation